Global Patient Derived Xenograft Models Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Patient Derived Xenograft Models will have significant change from previous year. According to our (LP Information) latest study, the global Patient Derived Xenograft Models market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Patient Derived Xenograft Models market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Patient Derived Xenograft Models market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Patient Derived Xenograft Models market, reaching US$ million by the year 2028. As for the Europe Patient Derived Xenograft Models landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Patient Derived Xenograft Models players cover Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology (US), and The Jackson Laboratory (US), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Patient Derived Xenograft Models market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Patient Derived Xenograft Models will have significant change from previous year. According to our (LP Information) latest study, the global Patient Derived Xenograft Models market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Patient Derived Xenograft Models market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Patient Derived Xenograft Models market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Patient Derived Xenograft Models market, reaching US$ million by the year 2028. As for the Europe Patient Derived Xenograft Models landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Patient Derived Xenograft Models players cover Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology (US), and The Jackson Laboratory (US), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Patient Derived Xenograft Models market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Mice Models
- Rat Models
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Research Institutions
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Crown Bioscience Inc. (US)
- WuXi AppTec (China)
- Champions Oncology (US)
- The Jackson Laboratory (US)
- ONCODESIGN (France)
- Charles River Laboratories International (US)
- EPO Berlin-Buch GmBH (Germany)
- Shanghai LIDE Biotech Co., Ltd (China)
- Xentech (France)
- Horizon Discovery Group PLC (UK)
- Urolead (France)
- Explora BioLabs (US)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Patient Derived Xenograft Models Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Patient Derived Xenograft Models by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Patient Derived Xenograft Models by Country/Region, 2017, 2022 & 2028
2.2 Patient Derived Xenograft Models Segment by Type
2.2.1 Mice Models
2.2.2 Rat Models
2.3 Patient Derived Xenograft Models Sales by Type
2.3.1 Global Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
2.3.2 Global Patient Derived Xenograft Models Revenue and Market Share by Type (2017-2022)
2.3.3 Global Patient Derived Xenograft Models Sale Price by Type (2017-2022)
2.4 Patient Derived Xenograft Models Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Contract Research Organizations
2.4.3 Academic & Research Institutions
2.5 Patient Derived Xenograft Models Sales by Application
2.5.1 Global Patient Derived Xenograft Models Sale Market Share by Application (2017-2022)
2.5.2 Global Patient Derived Xenograft Models Revenue and Market Share by Application (2017-2022)
2.5.3 Global Patient Derived Xenograft Models Sale Price by Application (2017-2022)
3 GLOBAL PATIENT DERIVED XENOGRAFT MODELS BY COMPANY
3.1 Global Patient Derived Xenograft Models Breakdown Data by Company
3.1.1 Global Patient Derived Xenograft Models Annual Sales by Company (2020-2022)
3.1.2 Global Patient Derived Xenograft Models Sales Market Share by Company (2020-2022)
3.2 Global Patient Derived Xenograft Models Annual Revenue by Company (2020-2022)
3.2.1 Global Patient Derived Xenograft Models Revenue by Company (2020-2022)
3.2.2 Global Patient Derived Xenograft Models Revenue Market Share by Company (2020-2022)
3.3 Global Patient Derived Xenograft Models Sale Price by Company
3.4 Key Manufacturers Patient Derived Xenograft Models Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Patient Derived Xenograft Models Product Location Distribution
3.4.2 Players Patient Derived Xenograft Models Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PATIENT DERIVED XENOGRAFT MODELS BY GEOGRAPHIC REGION
4.1 World Historic Patient Derived Xenograft Models Market Size by Geographic Region (2017-2022)
4.1.1 Global Patient Derived Xenograft Models Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Patient Derived Xenograft Models Annual Revenue by Geographic Region
4.2 World Historic Patient Derived Xenograft Models Market Size by Country/Region (2017-2022)
4.2.1 Global Patient Derived Xenograft Models Annual Sales by Country/Region (2017-2022)
4.2.2 Global Patient Derived Xenograft Models Annual Revenue by Country/Region
4.3 Americas Patient Derived Xenograft Models Sales Growth
4.4 APAC Patient Derived Xenograft Models Sales Growth
4.5 Europe Patient Derived Xenograft Models Sales Growth
4.6 Middle East & Africa Patient Derived Xenograft Models Sales Growth
5 AMERICAS
5.1 Americas Patient Derived Xenograft Models Sales by Country
5.1.1 Americas Patient Derived Xenograft Models Sales by Country (2017-2022)
5.1.2 Americas Patient Derived Xenograft Models Revenue by Country (2017-2022)
5.2 Americas Patient Derived Xenograft Models Sales by Type
5.3 Americas Patient Derived Xenograft Models Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Patient Derived Xenograft Models Sales by Region
6.1.1 APAC Patient Derived Xenograft Models Sales by Region (2017-2022)
6.1.2 APAC Patient Derived Xenograft Models Revenue by Region (2017-2022)
6.2 APAC Patient Derived Xenograft Models Sales by Type
6.3 APAC Patient Derived Xenograft Models Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Patient Derived Xenograft Models by Country
7.1.1 Europe Patient Derived Xenograft Models Sales by Country (2017-2022)
7.1.2 Europe Patient Derived Xenograft Models Revenue by Country (2017-2022)
7.2 Europe Patient Derived Xenograft Models Sales by Type
7.3 Europe Patient Derived Xenograft Models Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Patient Derived Xenograft Models by Country
8.1.1 Middle East & Africa Patient Derived Xenograft Models Sales by Country (2017-2022)
8.1.2 Middle East & Africa Patient Derived Xenograft Models Revenue by Country (2017-2022)
8.2 Middle East & Africa Patient Derived Xenograft Models Sales by Type
8.3 Middle East & Africa Patient Derived Xenograft Models Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Patient Derived Xenograft Models
10.3 Manufacturing Process Analysis of Patient Derived Xenograft Models
10.4 Industry Chain Structure of Patient Derived Xenograft Models
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Patient Derived Xenograft Models Distributors
11.3 Patient Derived Xenograft Models Customer
12 WORLD FORECAST REVIEW FOR PATIENT DERIVED XENOGRAFT MODELS BY GEOGRAPHIC REGION
12.1 Global Patient Derived Xenograft Models Market Size Forecast by Region
12.1.1 Global Patient Derived Xenograft Models Forecast by Region (2023-2028)
12.1.2 Global Patient Derived Xenograft Models Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Patient Derived Xenograft Models Forecast by Type
12.7 Global Patient Derived Xenograft Models Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Crown Bioscience Inc. (US)
13.1.1 Crown Bioscience Inc. (US) Company Information
13.1.2 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product Offered
13.1.3 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Crown Bioscience Inc. (US) Main Business Overview
13.1.5 Crown Bioscience Inc. (US) Latest Developments
13.2 WuXi AppTec (China)
13.2.1 WuXi AppTec (China) Company Information
13.2.2 WuXi AppTec (China) Patient Derived Xenograft Models Product Offered
13.2.3 WuXi AppTec (China) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 WuXi AppTec (China) Main Business Overview
13.2.5 WuXi AppTec (China) Latest Developments
13.3 Champions Oncology (US)
13.3.1 Champions Oncology (US) Company Information
13.3.2 Champions Oncology (US) Patient Derived Xenograft Models Product Offered
13.3.3 Champions Oncology (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Champions Oncology (US) Main Business Overview
13.3.5 Champions Oncology (US) Latest Developments
13.4 The Jackson Laboratory (US)
13.4.1 The Jackson Laboratory (US) Company Information
13.4.2 The Jackson Laboratory (US) Patient Derived Xenograft Models Product Offered
13.4.3 The Jackson Laboratory (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 The Jackson Laboratory (US) Main Business Overview
13.4.5 The Jackson Laboratory (US) Latest Developments
13.5 ONCODESIGN (France)
13.5.1 ONCODESIGN (France) Company Information
13.5.2 ONCODESIGN (France) Patient Derived Xenograft Models Product Offered
13.5.3 ONCODESIGN (France) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 ONCODESIGN (France) Main Business Overview
13.5.5 ONCODESIGN (France) Latest Developments
13.6 Charles River Laboratories International (US)
13.6.1 Charles River Laboratories International (US) Company Information
13.6.2 Charles River Laboratories International (US) Patient Derived Xenograft Models Product Offered
13.6.3 Charles River Laboratories International (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Charles River Laboratories International (US) Main Business Overview
13.6.5 Charles River Laboratories International (US) Latest Developments
13.7 EPO Berlin-Buch GmBH (Germany)
13.7.1 EPO Berlin-Buch GmBH (Germany) Company Information
13.7.2 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product Offered
13.7.3 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 EPO Berlin-Buch GmBH (Germany) Main Business Overview
13.7.5 EPO Berlin-Buch GmBH (Germany) Latest Developments
13.8 Shanghai LIDE Biotech Co., Ltd (China)
13.8.1 Shanghai LIDE Biotech Co., Ltd (China) Company Information
13.8.2 Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product Offered
13.8.3 Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Shanghai LIDE Biotech Co., Ltd (China) Main Business Overview
13.8.5 Shanghai LIDE Biotech Co., Ltd (China) Latest Developments
13.9 Xentech (France)
13.9.1 Xentech (France) Company Information
13.9.2 Xentech (France) Patient Derived Xenograft Models Product Offered
13.9.3 Xentech (France) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Xentech (France) Main Business Overview
13.9.5 Xentech (France) Latest Developments
13.10 Horizon Discovery Group PLC (UK)
13.10.1 Horizon Discovery Group PLC (UK) Company Information
13.10.2 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product Offered
13.10.3 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Horizon Discovery Group PLC (UK) Main Business Overview
13.10.5 Horizon Discovery Group PLC (UK) Latest Developments
13.11 Urolead (France)
13.11.1 Urolead (France) Company Information
13.11.2 Urolead (France) Patient Derived Xenograft Models Product Offered
13.11.3 Urolead (France) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Urolead (France) Main Business Overview
13.11.5 Urolead (France) Latest Developments
13.12 Explora BioLabs (US)
13.12.1 Explora BioLabs (US) Company Information
13.12.2 Explora BioLabs (US) Patient Derived Xenograft Models Product Offered
13.12.3 Explora BioLabs (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Explora BioLabs (US) Main Business Overview
13.12.5 Explora BioLabs (US) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Patient Derived Xenograft Models Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Patient Derived Xenograft Models by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Patient Derived Xenograft Models by Country/Region, 2017, 2022 & 2028
2.2 Patient Derived Xenograft Models Segment by Type
2.2.1 Mice Models
2.2.2 Rat Models
2.3 Patient Derived Xenograft Models Sales by Type
2.3.1 Global Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
2.3.2 Global Patient Derived Xenograft Models Revenue and Market Share by Type (2017-2022)
2.3.3 Global Patient Derived Xenograft Models Sale Price by Type (2017-2022)
2.4 Patient Derived Xenograft Models Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Contract Research Organizations
2.4.3 Academic & Research Institutions
2.5 Patient Derived Xenograft Models Sales by Application
2.5.1 Global Patient Derived Xenograft Models Sale Market Share by Application (2017-2022)
2.5.2 Global Patient Derived Xenograft Models Revenue and Market Share by Application (2017-2022)
2.5.3 Global Patient Derived Xenograft Models Sale Price by Application (2017-2022)
3 GLOBAL PATIENT DERIVED XENOGRAFT MODELS BY COMPANY
3.1 Global Patient Derived Xenograft Models Breakdown Data by Company
3.1.1 Global Patient Derived Xenograft Models Annual Sales by Company (2020-2022)
3.1.2 Global Patient Derived Xenograft Models Sales Market Share by Company (2020-2022)
3.2 Global Patient Derived Xenograft Models Annual Revenue by Company (2020-2022)
3.2.1 Global Patient Derived Xenograft Models Revenue by Company (2020-2022)
3.2.2 Global Patient Derived Xenograft Models Revenue Market Share by Company (2020-2022)
3.3 Global Patient Derived Xenograft Models Sale Price by Company
3.4 Key Manufacturers Patient Derived Xenograft Models Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Patient Derived Xenograft Models Product Location Distribution
3.4.2 Players Patient Derived Xenograft Models Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PATIENT DERIVED XENOGRAFT MODELS BY GEOGRAPHIC REGION
4.1 World Historic Patient Derived Xenograft Models Market Size by Geographic Region (2017-2022)
4.1.1 Global Patient Derived Xenograft Models Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Patient Derived Xenograft Models Annual Revenue by Geographic Region
4.2 World Historic Patient Derived Xenograft Models Market Size by Country/Region (2017-2022)
4.2.1 Global Patient Derived Xenograft Models Annual Sales by Country/Region (2017-2022)
4.2.2 Global Patient Derived Xenograft Models Annual Revenue by Country/Region
4.3 Americas Patient Derived Xenograft Models Sales Growth
4.4 APAC Patient Derived Xenograft Models Sales Growth
4.5 Europe Patient Derived Xenograft Models Sales Growth
4.6 Middle East & Africa Patient Derived Xenograft Models Sales Growth
5 AMERICAS
5.1 Americas Patient Derived Xenograft Models Sales by Country
5.1.1 Americas Patient Derived Xenograft Models Sales by Country (2017-2022)
5.1.2 Americas Patient Derived Xenograft Models Revenue by Country (2017-2022)
5.2 Americas Patient Derived Xenograft Models Sales by Type
5.3 Americas Patient Derived Xenograft Models Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Patient Derived Xenograft Models Sales by Region
6.1.1 APAC Patient Derived Xenograft Models Sales by Region (2017-2022)
6.1.2 APAC Patient Derived Xenograft Models Revenue by Region (2017-2022)
6.2 APAC Patient Derived Xenograft Models Sales by Type
6.3 APAC Patient Derived Xenograft Models Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Patient Derived Xenograft Models by Country
7.1.1 Europe Patient Derived Xenograft Models Sales by Country (2017-2022)
7.1.2 Europe Patient Derived Xenograft Models Revenue by Country (2017-2022)
7.2 Europe Patient Derived Xenograft Models Sales by Type
7.3 Europe Patient Derived Xenograft Models Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Patient Derived Xenograft Models by Country
8.1.1 Middle East & Africa Patient Derived Xenograft Models Sales by Country (2017-2022)
8.1.2 Middle East & Africa Patient Derived Xenograft Models Revenue by Country (2017-2022)
8.2 Middle East & Africa Patient Derived Xenograft Models Sales by Type
8.3 Middle East & Africa Patient Derived Xenograft Models Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Patient Derived Xenograft Models
10.3 Manufacturing Process Analysis of Patient Derived Xenograft Models
10.4 Industry Chain Structure of Patient Derived Xenograft Models
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Patient Derived Xenograft Models Distributors
11.3 Patient Derived Xenograft Models Customer
12 WORLD FORECAST REVIEW FOR PATIENT DERIVED XENOGRAFT MODELS BY GEOGRAPHIC REGION
12.1 Global Patient Derived Xenograft Models Market Size Forecast by Region
12.1.1 Global Patient Derived Xenograft Models Forecast by Region (2023-2028)
12.1.2 Global Patient Derived Xenograft Models Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Patient Derived Xenograft Models Forecast by Type
12.7 Global Patient Derived Xenograft Models Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Crown Bioscience Inc. (US)
13.1.1 Crown Bioscience Inc. (US) Company Information
13.1.2 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product Offered
13.1.3 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Crown Bioscience Inc. (US) Main Business Overview
13.1.5 Crown Bioscience Inc. (US) Latest Developments
13.2 WuXi AppTec (China)
13.2.1 WuXi AppTec (China) Company Information
13.2.2 WuXi AppTec (China) Patient Derived Xenograft Models Product Offered
13.2.3 WuXi AppTec (China) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 WuXi AppTec (China) Main Business Overview
13.2.5 WuXi AppTec (China) Latest Developments
13.3 Champions Oncology (US)
13.3.1 Champions Oncology (US) Company Information
13.3.2 Champions Oncology (US) Patient Derived Xenograft Models Product Offered
13.3.3 Champions Oncology (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Champions Oncology (US) Main Business Overview
13.3.5 Champions Oncology (US) Latest Developments
13.4 The Jackson Laboratory (US)
13.4.1 The Jackson Laboratory (US) Company Information
13.4.2 The Jackson Laboratory (US) Patient Derived Xenograft Models Product Offered
13.4.3 The Jackson Laboratory (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 The Jackson Laboratory (US) Main Business Overview
13.4.5 The Jackson Laboratory (US) Latest Developments
13.5 ONCODESIGN (France)
13.5.1 ONCODESIGN (France) Company Information
13.5.2 ONCODESIGN (France) Patient Derived Xenograft Models Product Offered
13.5.3 ONCODESIGN (France) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 ONCODESIGN (France) Main Business Overview
13.5.5 ONCODESIGN (France) Latest Developments
13.6 Charles River Laboratories International (US)
13.6.1 Charles River Laboratories International (US) Company Information
13.6.2 Charles River Laboratories International (US) Patient Derived Xenograft Models Product Offered
13.6.3 Charles River Laboratories International (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Charles River Laboratories International (US) Main Business Overview
13.6.5 Charles River Laboratories International (US) Latest Developments
13.7 EPO Berlin-Buch GmBH (Germany)
13.7.1 EPO Berlin-Buch GmBH (Germany) Company Information
13.7.2 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product Offered
13.7.3 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 EPO Berlin-Buch GmBH (Germany) Main Business Overview
13.7.5 EPO Berlin-Buch GmBH (Germany) Latest Developments
13.8 Shanghai LIDE Biotech Co., Ltd (China)
13.8.1 Shanghai LIDE Biotech Co., Ltd (China) Company Information
13.8.2 Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product Offered
13.8.3 Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Shanghai LIDE Biotech Co., Ltd (China) Main Business Overview
13.8.5 Shanghai LIDE Biotech Co., Ltd (China) Latest Developments
13.9 Xentech (France)
13.9.1 Xentech (France) Company Information
13.9.2 Xentech (France) Patient Derived Xenograft Models Product Offered
13.9.3 Xentech (France) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Xentech (France) Main Business Overview
13.9.5 Xentech (France) Latest Developments
13.10 Horizon Discovery Group PLC (UK)
13.10.1 Horizon Discovery Group PLC (UK) Company Information
13.10.2 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product Offered
13.10.3 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Horizon Discovery Group PLC (UK) Main Business Overview
13.10.5 Horizon Discovery Group PLC (UK) Latest Developments
13.11 Urolead (France)
13.11.1 Urolead (France) Company Information
13.11.2 Urolead (France) Patient Derived Xenograft Models Product Offered
13.11.3 Urolead (France) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Urolead (France) Main Business Overview
13.11.5 Urolead (France) Latest Developments
13.12 Explora BioLabs (US)
13.12.1 Explora BioLabs (US) Company Information
13.12.2 Explora BioLabs (US) Patient Derived Xenograft Models Product Offered
13.12.3 Explora BioLabs (US) Patient Derived Xenograft Models Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Explora BioLabs (US) Main Business Overview
13.12.5 Explora BioLabs (US) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Patient Derived Xenograft Models Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Patient Derived Xenograft Models Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Mice Models
Table 4. Major Players of Rat Models
Table 5. Global Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 6. Global Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 7. Global Patient Derived Xenograft Models Revenue by Type (2017-2022) & ($ million)
Table 8. Global Patient Derived Xenograft Models Revenue Market Share by Type (2017-2022)
Table 9. Global Patient Derived Xenograft Models Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 11. Global Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 12. Global Patient Derived Xenograft Models Revenue by Application (2017-2022)
Table 13. Global Patient Derived Xenograft Models Revenue Market Share by Application (2017-2022)
Table 14. Global Patient Derived Xenograft Models Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Patient Derived Xenograft Models Sales by Company (2020-2022) & (K Units)
Table 16. Global Patient Derived Xenograft Models Sales Market Share by Company (2020-2022)
Table 17. Global Patient Derived Xenograft Models Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Patient Derived Xenograft Models Revenue Market Share by Company (2020-2022)
Table 19. Global Patient Derived Xenograft Models Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Patient Derived Xenograft Models Producing Area Distribution and Sales Area
Table 21. Players Patient Derived Xenograft Models Products Offered
Table 22. Patient Derived Xenograft Models Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Patient Derived Xenograft Models Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Patient Derived Xenograft Models Sales Market Share Geographic Region (2017-2022)
Table 27. Global Patient Derived Xenograft Models Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Patient Derived Xenograft Models Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Patient Derived Xenograft Models Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Patient Derived Xenograft Models Sales Market Share by Country/Region (2017-2022)
Table 31. Global Patient Derived Xenograft Models Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Patient Derived Xenograft Models Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
Table 34. Americas Patient Derived Xenograft Models Sales Market Share by Country (2017-2022)
Table 35. Americas Patient Derived Xenograft Models Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Patient Derived Xenograft Models Revenue Market Share by Country (2017-2022)
Table 37. Americas Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 38. Americas Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 39. Americas Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 40. Americas Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 41. APAC Patient Derived Xenograft Models Sales by Region (2017-2022) & (K Units)
Table 42. APAC Patient Derived Xenograft Models Sales Market Share by Region (2017-2022)
Table 43. APAC Patient Derived Xenograft Models Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Patient Derived Xenograft Models Revenue Market Share by Region (2017-2022)
Table 45. APAC Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 46. APAC Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 47. APAC Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 48. APAC Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 49. Europe Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
Table 50. Europe Patient Derived Xenograft Models Sales Market Share by Country (2017-2022)
Table 51. Europe Patient Derived Xenograft Models Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Patient Derived Xenograft Models Revenue Market Share by Country (2017-2022)
Table 53. Europe Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 54. Europe Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 55. Europe Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 56. Europe Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Patient Derived Xenograft Models Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Patient Derived Xenograft Models Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Patient Derived Xenograft Models Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Patient Derived Xenograft Models
Table 66. Key Market Challenges & Risks of Patient Derived Xenograft Models
Table 67. Key Industry Trends of Patient Derived Xenograft Models
Table 68. Patient Derived Xenograft Models Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Patient Derived Xenograft Models Distributors List
Table 71. Patient Derived Xenograft Models Customer List
Table 72. Global Patient Derived Xenograft Models Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Patient Derived Xenograft Models Sales Market Forecast by Region
Table 74. Global Patient Derived Xenograft Models Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Patient Derived Xenograft Models Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Patient Derived Xenograft Models Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Patient Derived Xenograft Models Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Patient Derived Xenograft Models Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Patient Derived Xenograft Models Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Patient Derived Xenograft Models Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Patient Derived Xenograft Models Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Patient Derived Xenograft Models Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Patient Derived Xenograft Models Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Patient Derived Xenograft Models Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Patient Derived Xenograft Models Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Patient Derived Xenograft Models Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Patient Derived Xenograft Models Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Patient Derived Xenograft Models Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Patient Derived Xenograft Models Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Patient Derived Xenograft Models Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Patient Derived Xenograft Models Revenue Market Share Forecast by Application (2023-2028)
Table 92. Crown Bioscience Inc. (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 93. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product Offered
Table 94. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Crown Bioscience Inc. (US) Main Business
Table 96. Crown Bioscience Inc. (US) Latest Developments
Table 97. WuXi AppTec (China) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 98. WuXi AppTec (China) Patient Derived Xenograft Models Product Offered
Table 99. WuXi AppTec (China) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. WuXi AppTec (China) Main Business
Table 101. WuXi AppTec (China) Latest Developments
Table 102. Champions Oncology (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 103. Champions Oncology (US) Patient Derived Xenograft Models Product Offered
Table 104. Champions Oncology (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Champions Oncology (US) Main Business
Table 106. Champions Oncology (US) Latest Developments
Table 107. The Jackson Laboratory (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 108. The Jackson Laboratory (US) Patient Derived Xenograft Models Product Offered
Table 109. The Jackson Laboratory (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. The Jackson Laboratory (US) Main Business
Table 111. The Jackson Laboratory (US) Latest Developments
Table 112. ONCODESIGN (France) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 113. ONCODESIGN (France) Patient Derived Xenograft Models Product Offered
Table 114. ONCODESIGN (France) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. ONCODESIGN (France) Main Business
Table 116. ONCODESIGN (France) Latest Developments
Table 117. Charles River Laboratories International (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 118. Charles River Laboratories International (US) Patient Derived Xenograft Models Product Offered
Table 119. Charles River Laboratories International (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Charles River Laboratories International (US) Main Business
Table 121. Charles River Laboratories International (US) Latest Developments
Table 122. EPO Berlin-Buch GmBH (Germany) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 123. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product Offered
Table 124. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. EPO Berlin-Buch GmBH (Germany) Main Business
Table 126. EPO Berlin-Buch GmBH (Germany) Latest Developments
Table 127. Shanghai LIDE Biotech Co., Ltd (China) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 128. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product Offered
Table 129. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Shanghai LIDE Biotech Co., Ltd (China) Main Business
Table 131. Shanghai LIDE Biotech Co., Ltd (China) Latest Developments
Table 132. Xentech (France) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 133. Xentech (France) Patient Derived Xenograft Models Product Offered
Table 134. Xentech (France) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Xentech (France) Main Business
Table 136. Xentech (France) Latest Developments
Table 137. Horizon Discovery Group PLC (UK) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 138. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product Offered
Table 139. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Horizon Discovery Group PLC (UK) Main Business
Table 141. Horizon Discovery Group PLC (UK) Latest Developments
Table 142. Urolead (France) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 143. Urolead (France) Patient Derived Xenograft Models Product Offered
Table 144. Urolead (France) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Urolead (France) Main Business
Table 146. Urolead (France) Latest Developments
Table 147. Explora BioLabs (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 148. Explora BioLabs (US) Patient Derived Xenograft Models Product Offered
Table 149. Explora BioLabs (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Explora BioLabs (US) Main Business
Table 151. Explora BioLabs (US) Latest Developments
Table 1. Patient Derived Xenograft Models Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Patient Derived Xenograft Models Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Mice Models
Table 4. Major Players of Rat Models
Table 5. Global Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 6. Global Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 7. Global Patient Derived Xenograft Models Revenue by Type (2017-2022) & ($ million)
Table 8. Global Patient Derived Xenograft Models Revenue Market Share by Type (2017-2022)
Table 9. Global Patient Derived Xenograft Models Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 11. Global Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 12. Global Patient Derived Xenograft Models Revenue by Application (2017-2022)
Table 13. Global Patient Derived Xenograft Models Revenue Market Share by Application (2017-2022)
Table 14. Global Patient Derived Xenograft Models Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Patient Derived Xenograft Models Sales by Company (2020-2022) & (K Units)
Table 16. Global Patient Derived Xenograft Models Sales Market Share by Company (2020-2022)
Table 17. Global Patient Derived Xenograft Models Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Patient Derived Xenograft Models Revenue Market Share by Company (2020-2022)
Table 19. Global Patient Derived Xenograft Models Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Patient Derived Xenograft Models Producing Area Distribution and Sales Area
Table 21. Players Patient Derived Xenograft Models Products Offered
Table 22. Patient Derived Xenograft Models Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Patient Derived Xenograft Models Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Patient Derived Xenograft Models Sales Market Share Geographic Region (2017-2022)
Table 27. Global Patient Derived Xenograft Models Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Patient Derived Xenograft Models Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Patient Derived Xenograft Models Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Patient Derived Xenograft Models Sales Market Share by Country/Region (2017-2022)
Table 31. Global Patient Derived Xenograft Models Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Patient Derived Xenograft Models Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
Table 34. Americas Patient Derived Xenograft Models Sales Market Share by Country (2017-2022)
Table 35. Americas Patient Derived Xenograft Models Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Patient Derived Xenograft Models Revenue Market Share by Country (2017-2022)
Table 37. Americas Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 38. Americas Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 39. Americas Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 40. Americas Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 41. APAC Patient Derived Xenograft Models Sales by Region (2017-2022) & (K Units)
Table 42. APAC Patient Derived Xenograft Models Sales Market Share by Region (2017-2022)
Table 43. APAC Patient Derived Xenograft Models Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Patient Derived Xenograft Models Revenue Market Share by Region (2017-2022)
Table 45. APAC Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 46. APAC Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 47. APAC Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 48. APAC Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 49. Europe Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
Table 50. Europe Patient Derived Xenograft Models Sales Market Share by Country (2017-2022)
Table 51. Europe Patient Derived Xenograft Models Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Patient Derived Xenograft Models Revenue Market Share by Country (2017-2022)
Table 53. Europe Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 54. Europe Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 55. Europe Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 56. Europe Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Patient Derived Xenograft Models Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Patient Derived Xenograft Models Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Patient Derived Xenograft Models Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Patient Derived Xenograft Models Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Patient Derived Xenograft Models
Table 66. Key Market Challenges & Risks of Patient Derived Xenograft Models
Table 67. Key Industry Trends of Patient Derived Xenograft Models
Table 68. Patient Derived Xenograft Models Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Patient Derived Xenograft Models Distributors List
Table 71. Patient Derived Xenograft Models Customer List
Table 72. Global Patient Derived Xenograft Models Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Patient Derived Xenograft Models Sales Market Forecast by Region
Table 74. Global Patient Derived Xenograft Models Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Patient Derived Xenograft Models Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Patient Derived Xenograft Models Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Patient Derived Xenograft Models Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Patient Derived Xenograft Models Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Patient Derived Xenograft Models Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Patient Derived Xenograft Models Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Patient Derived Xenograft Models Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Patient Derived Xenograft Models Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Patient Derived Xenograft Models Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Patient Derived Xenograft Models Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Patient Derived Xenograft Models Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Patient Derived Xenograft Models Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Patient Derived Xenograft Models Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Patient Derived Xenograft Models Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Patient Derived Xenograft Models Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Patient Derived Xenograft Models Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Patient Derived Xenograft Models Revenue Market Share Forecast by Application (2023-2028)
Table 92. Crown Bioscience Inc. (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 93. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product Offered
Table 94. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Crown Bioscience Inc. (US) Main Business
Table 96. Crown Bioscience Inc. (US) Latest Developments
Table 97. WuXi AppTec (China) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 98. WuXi AppTec (China) Patient Derived Xenograft Models Product Offered
Table 99. WuXi AppTec (China) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. WuXi AppTec (China) Main Business
Table 101. WuXi AppTec (China) Latest Developments
Table 102. Champions Oncology (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 103. Champions Oncology (US) Patient Derived Xenograft Models Product Offered
Table 104. Champions Oncology (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Champions Oncology (US) Main Business
Table 106. Champions Oncology (US) Latest Developments
Table 107. The Jackson Laboratory (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 108. The Jackson Laboratory (US) Patient Derived Xenograft Models Product Offered
Table 109. The Jackson Laboratory (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. The Jackson Laboratory (US) Main Business
Table 111. The Jackson Laboratory (US) Latest Developments
Table 112. ONCODESIGN (France) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 113. ONCODESIGN (France) Patient Derived Xenograft Models Product Offered
Table 114. ONCODESIGN (France) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. ONCODESIGN (France) Main Business
Table 116. ONCODESIGN (France) Latest Developments
Table 117. Charles River Laboratories International (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 118. Charles River Laboratories International (US) Patient Derived Xenograft Models Product Offered
Table 119. Charles River Laboratories International (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Charles River Laboratories International (US) Main Business
Table 121. Charles River Laboratories International (US) Latest Developments
Table 122. EPO Berlin-Buch GmBH (Germany) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 123. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product Offered
Table 124. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. EPO Berlin-Buch GmBH (Germany) Main Business
Table 126. EPO Berlin-Buch GmBH (Germany) Latest Developments
Table 127. Shanghai LIDE Biotech Co., Ltd (China) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 128. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product Offered
Table 129. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Shanghai LIDE Biotech Co., Ltd (China) Main Business
Table 131. Shanghai LIDE Biotech Co., Ltd (China) Latest Developments
Table 132. Xentech (France) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 133. Xentech (France) Patient Derived Xenograft Models Product Offered
Table 134. Xentech (France) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Xentech (France) Main Business
Table 136. Xentech (France) Latest Developments
Table 137. Horizon Discovery Group PLC (UK) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 138. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product Offered
Table 139. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Horizon Discovery Group PLC (UK) Main Business
Table 141. Horizon Discovery Group PLC (UK) Latest Developments
Table 142. Urolead (France) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 143. Urolead (France) Patient Derived Xenograft Models Product Offered
Table 144. Urolead (France) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Urolead (France) Main Business
Table 146. Urolead (France) Latest Developments
Table 147. Explora BioLabs (US) Basic Information, Patient Derived Xenograft Models Manufacturing Base, Sales Area and Its Competitors
Table 148. Explora BioLabs (US) Patient Derived Xenograft Models Product Offered
Table 149. Explora BioLabs (US) Patient Derived Xenograft Models Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Explora BioLabs (US) Main Business
Table 151. Explora BioLabs (US) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Patient Derived Xenograft Models
Figure 2. Patient Derived Xenograft Models Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Patient Derived Xenograft Models Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Patient Derived Xenograft Models Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Patient Derived Xenograft Models Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Mice Models
Figure 10. Product Picture of Rat Models
Figure 11. Global Patient Derived Xenograft Models Sales Market Share by Type in 2021
Figure 12. Global Patient Derived Xenograft Models Revenue Market Share by Type (2017-2022)
Figure 13. Patient Derived Xenograft Models Consumed in Pharmaceutical & Biotechnology Companies
Figure 14. Global Patient Derived Xenograft Models Market: Pharmaceutical & Biotechnology Companies (2017-2022) & (K Units)
Figure 15. Patient Derived Xenograft Models Consumed in Contract Research Organizations
Figure 16. Global Patient Derived Xenograft Models Market: Contract Research Organizations (2017-2022) & (K Units)
Figure 17. Patient Derived Xenograft Models Consumed in Academic & Research Institutions
Figure 18. Global Patient Derived Xenograft Models Market: Academic & Research Institutions (2017-2022) & (K Units)
Figure 19. Global Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Figure 20. Global Patient Derived Xenograft Models Revenue Market Share by Application in 2021
Figure 21. Patient Derived Xenograft Models Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Patient Derived Xenograft Models Revenue Market Share by Company in 2021
Figure 23. Global Patient Derived Xenograft Models Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Patient Derived Xenograft Models Revenue Market Share by Geographic Region in 2021
Figure 25. Global Patient Derived Xenograft Models Sales Market Share by Region (2017-2022)
Figure 26. Global Patient Derived Xenograft Models Revenue Market Share by Country/Region in 2021
Figure 27. Americas Patient Derived Xenograft Models Sales 2017-2022 (K Units)
Figure 28. Americas Patient Derived Xenograft Models Revenue 2017-2022 ($ Millions)
Figure 29. APAC Patient Derived Xenograft Models Sales 2017-2022 (K Units)
Figure 30. APAC Patient Derived Xenograft Models Revenue 2017-2022 ($ Millions)
Figure 31. Europe Patient Derived Xenograft Models Sales 2017-2022 (K Units)
Figure 32. Europe Patient Derived Xenograft Models Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Patient Derived Xenograft Models Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Patient Derived Xenograft Models Revenue 2017-2022 ($ Millions)
Figure 35. Americas Patient Derived Xenograft Models Sales Market Share by Country in 2021
Figure 36. Americas Patient Derived Xenograft Models Revenue Market Share by Country in 2021
Figure 37. United States Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Patient Derived Xenograft Models Sales Market Share by Region in 2021
Figure 42. APAC Patient Derived Xenograft Models Revenue Market Share by Regions in 2021
Figure 43. China Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Patient Derived Xenograft Models Sales Market Share by Country in 2021
Figure 50. Europe Patient Derived Xenograft Models Revenue Market Share by Country in 2021
Figure 51. Germany Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Patient Derived Xenograft Models Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Patient Derived Xenograft Models Revenue Market Share by Country in 2021
Figure 58. Egypt Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Patient Derived Xenograft Models in 2021
Figure 64. Manufacturing Process Analysis of Patient Derived Xenograft Models
Figure 65. Industry Chain Structure of Patient Derived Xenograft Models
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Patient Derived Xenograft Models
Figure 2. Patient Derived Xenograft Models Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Patient Derived Xenograft Models Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Patient Derived Xenograft Models Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Patient Derived Xenograft Models Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Mice Models
Figure 10. Product Picture of Rat Models
Figure 11. Global Patient Derived Xenograft Models Sales Market Share by Type in 2021
Figure 12. Global Patient Derived Xenograft Models Revenue Market Share by Type (2017-2022)
Figure 13. Patient Derived Xenograft Models Consumed in Pharmaceutical & Biotechnology Companies
Figure 14. Global Patient Derived Xenograft Models Market: Pharmaceutical & Biotechnology Companies (2017-2022) & (K Units)
Figure 15. Patient Derived Xenograft Models Consumed in Contract Research Organizations
Figure 16. Global Patient Derived Xenograft Models Market: Contract Research Organizations (2017-2022) & (K Units)
Figure 17. Patient Derived Xenograft Models Consumed in Academic & Research Institutions
Figure 18. Global Patient Derived Xenograft Models Market: Academic & Research Institutions (2017-2022) & (K Units)
Figure 19. Global Patient Derived Xenograft Models Sales Market Share by Application (2017-2022)
Figure 20. Global Patient Derived Xenograft Models Revenue Market Share by Application in 2021
Figure 21. Patient Derived Xenograft Models Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Patient Derived Xenograft Models Revenue Market Share by Company in 2021
Figure 23. Global Patient Derived Xenograft Models Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Patient Derived Xenograft Models Revenue Market Share by Geographic Region in 2021
Figure 25. Global Patient Derived Xenograft Models Sales Market Share by Region (2017-2022)
Figure 26. Global Patient Derived Xenograft Models Revenue Market Share by Country/Region in 2021
Figure 27. Americas Patient Derived Xenograft Models Sales 2017-2022 (K Units)
Figure 28. Americas Patient Derived Xenograft Models Revenue 2017-2022 ($ Millions)
Figure 29. APAC Patient Derived Xenograft Models Sales 2017-2022 (K Units)
Figure 30. APAC Patient Derived Xenograft Models Revenue 2017-2022 ($ Millions)
Figure 31. Europe Patient Derived Xenograft Models Sales 2017-2022 (K Units)
Figure 32. Europe Patient Derived Xenograft Models Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Patient Derived Xenograft Models Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Patient Derived Xenograft Models Revenue 2017-2022 ($ Millions)
Figure 35. Americas Patient Derived Xenograft Models Sales Market Share by Country in 2021
Figure 36. Americas Patient Derived Xenograft Models Revenue Market Share by Country in 2021
Figure 37. United States Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Patient Derived Xenograft Models Sales Market Share by Region in 2021
Figure 42. APAC Patient Derived Xenograft Models Revenue Market Share by Regions in 2021
Figure 43. China Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Patient Derived Xenograft Models Sales Market Share by Country in 2021
Figure 50. Europe Patient Derived Xenograft Models Revenue Market Share by Country in 2021
Figure 51. Germany Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Patient Derived Xenograft Models Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Patient Derived Xenograft Models Revenue Market Share by Country in 2021
Figure 58. Egypt Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Patient Derived Xenograft Models Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Patient Derived Xenograft Models in 2021
Figure 64. Manufacturing Process Analysis of Patient Derived Xenograft Models
Figure 65. Industry Chain Structure of Patient Derived Xenograft Models
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
